Business development and corporate strategy executive joins Board as Company advances its clinical programs and partnering activity BRADENTON, Fla., July 30, 2026 /PRNewswire/ -- Continuity Biosciences today announced the appointment of Vicky Papoutsis to its Board of Directors. Vicky brings more than 25 years of biopharmaceutical business development and corporate strategy experience to the Board as the Company advances its clinical and preclinical programs and expands its partnering activity. The appointment comes at an important stage as Continuity Biosciences moves from platform dev…READ FULL ARTICLE
